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Abstract
Background: Contagious bovine pleuropneumonia (CBPP) is a mycoplasmal disease caused by Mycoplasma mycoides
subsp. mycoides SC (MmmSC). Since the disease is a serious problem that can affect cattle production in parts of Africa,
there is a need for an effective and economical vaccine. Identifying which of the causative agent's proteins trigger
potentially protective immune responses is an important step towards developing a subunit vaccine. Accordingly, the
purpose of this study was to determine whether phage display combined with bioinformatics could be used to narrow
the search for genes that code for potentially immunogenic proteins of MmmSC. Since the production of IgG2 and IgA
are associated with a Th1 cellular immune response which is implicated in protection against CBPP, antigens which elicit
these immunoglobulin subclasses may be useful in developing a subunit vaccine.
Results: A filamentous phage library displaying a repertoire of peptides expressed by fragments of the genome of
MmmSC was constructed. It was subjected to selection using antibodies from naturally- and experimentally-infected
cattle. Mycoplasmal genes were identified by matching the nucleotide sequences of DNA from immunoselected phage
particles with the mycoplasmal genome. This allowed a catalogue of genes coding for the proteins that elicited an immune
response to be compiled. Using this method together with computer algorithms designed to score parameters that
influence surface accessibility and hence potential antigenicity, five genes (abc, gapN, glpO, lppB and ptsG) were chosen to
be expressed in Escherichia coli. After appropriate site-directed mutagenesis, polypeptides representing portions of each
of these proteins were tested for immunoreactivity. Of these five, polypeptides representing expression products of abc
and lppB were recognised on immunoblots by sera obtained from cattle during a natural outbreak of the disease.
Conclusion: Since phage display physically couples phenotype with genotype, it was used to compile a list of sequences
that code for MmmSC proteins bearing epitopes which were recognised by antibodies in the serum of infected animals.
Together with the appropriate bioinformatic analyses, this approach provided several potentially useful vaccine or
diagnostic leads. The phage display step empirically identified sequences by their interaction with antibodies which
accordingly reduced the number of ORFs that had to be expressed for testing. This is a particular advantage when
working with MmmSC since the mycoplasmal codon for tryptophan needs to be mutated to prevent it from being
translated as a stop in E. coli.
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Background
Contagious bovine pleuropneumonia (CBPP), a pulmo-
nary disease caused by Mycoplasma mycoides subsp.
mycoides SC (MmmSC) is a major constraint to cattle pro-
duction in Africa [1]. The current vaccines are not always
fully effective [2] and there remains an urgent need to con-
trol or even eradicate the disease. Although the nucleotide
sequence of the MmmSC type strain PG1 genome is avail-
able, the proteins responsible for protection have not
been identified. Accordingly, an important step towards a
subunit vaccine would be to identify which of the poten-
tially large number of antigens encoded in its genome [3-
5] actually trigger immune responses during infection.
Serum antibodies are likely to be involved in immunity
since passive transfer of sera from recovered cattle can pro-
tect recipient calves [6,7], but Th1 memory lymphocytes
and γδ T-cells are also active [8-10]. Identifying which
antigens evoke one or more of these immune pathways
therefore remains a key step in developing a subunit-
based CBPP vaccine [11].
Phage display [12] makes it possible to identify antigenic
proteins by using antibodies from an immune source to
select binding peptides from a large repertoire of random
amino acid sequences [13]. Fragmented-genome or "shot-
gun" display libraries [14] can directly identify genes that
code for the proteins of which the immunoselected pep-
tides form a part. Provided that artefactual binders
expressed by frame-shifted or incorrectly orientated
inserts are excluded [15], matching the sequence coding
for an antigenic peptide with the sequence of the genome
from which it is derived locates the encoding gene. The
first MmmSC display library was constructed by Persson
and co-workers [16] and more recently, the approach was
also applied to Mycoplasma hyopneumoniae [17] as a way of
identifying immunogenic polypeptides.
To locate genes coding for potentially immunogenic pro-
teins, enzymatically-generated fragments of MmmSC
chromosomal DNA were used to construct a genome-spe-
cific filamentous phage display library which was sub-
jected to selection using antibodies from a CBPP outbreak
in Botswana [18] and an experimentally infected animal
from Mali designated C11 [19]. CD4+ T-cell activation and
IFNγ release are associated with an IgG2 humoral
immune response [20] while IgA is associated with local
mucosal immunity. Accordingly, both immunoglobulin
classes were used separately to select peptides as well as
using total IgG. Using this approach together with compu-
ter algorithms designed to identify linear B-cell epitopes
[21], five genes were chosen to be expressed for further
analysis and testing to establish whether they were recog-
nised by sera from cattle obtained during a natural out-
break of the disease.
Results
Construction of a fragmented-genome library
A pIII fusion protein phage display library of approxi-
mately 4 × 105 primary clones displaying peptides derived
from the MmmSC genome was constructed by ligating
DNA fragments ranging in size from approximately 30 to
900 bp as determined by agarose gel electrophoresis into
a filamentous phage display vector. The probability of the
genome being represented was 0.97 if the average insert
size was 240 bp. DNA sequencing of 16 arbitrarily-chosen
clones showed no obvious bias towards any particular
region of the mycoplasmal genome. Of the 16, two copies
of one of the sequenced DNA inserts were in-frame and in
the correct orientation. The largest insert was 178 base
pairs and the smallest 52.
To verify that the library was large and diverse enough to
identify other unknown MmmSC antigens, it was first
screened in a defined model system by panning on
immuno-purified IgG prepared from a rabbit immune
serum directed against amino acid residues 328-478 of the
proline-rich MmmSC glycoprotein which is coded for by
ORF5 (EMBL/GenBank accession number CAE77151).
Multiple copies of overlapping peptides that mapped to a
defined region on the target glycoprotein spanning resi-
dues 333 to 445 were selected (Figure 1).
Identification of antigenic peptides
Panning experiments aimed at selecting phage displayed
peptides that were recognised by the total serum IgG, the
IgG2 component and the IgA subpopulation of animal
C11 and pooled serum from seven cattle affected by a
CBPP outbreak in Botswana were performed. Clones
selected by each immunoglobulin class were randomly
chosen for DNA sequencing. After panning, all clones
were in-frame and without stops. Fifteen peptides recog-
nised by the total IgG preparation from the serum of ani-
mal C11 matched regions in eight different MmmSC
proteins in the EMBL/GenBank database, while 29 pep-
tides that had been selected using IgG2 corresponded with
Schematic representation showing alignment of the hypo- thetical proline-rich glycoprotein ORF5 with selected phage  fusion peptides Figure 1
Schematic representation showing alignment of the 
hypothetical proline-rich glycoprotein ORF5 with 
selected phage fusion peptides. Antigenic regions sug-
gested by the presence of overlapping sequences located 
between amino acid residues 358-365 and 388-410 are indi-
cated by shading.
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regions on 17 different proteins (Table 1). The library was
not panned with total serum IgG from Botswana but pep-
tides were selected using IgG2 which matched parts of
four of the proteins identified by the C11 antiserum
(GyrB, GlpO, LppB and Abc). Bronchoalveolar lavage
(BAL) IgA from animal C11 specifically selected four pep-
tides that could be correlated with portions of MmmSC
proteins while the Botswana serum selected six peptides
that matched three MmmSC proteins. A single C11 IgG2
peptide matched MmmSC glyceraldehyde-3-phosphate
dehydrogenase (GapN) which was also identified by one
C11 IgA peptide. Four peptides that were isolated with
C11 IgG2 matched the ABC transporter, substrate-binding
component protein (Abc). This protein was also identified
by the IgG from Mali (i.e. animal C11) and IgG2 and IgA
from the Botswana serum pool. Glycerol-3-phosphate
oxidase (GlpO) was selected by peptides from both C11
and Botswana serum IgG2. Three of the Botswana IgA
peptides matched to the mycoplasmal prolipoprotein B
(LppB) amino acid sequence. This protein was also
selected with both the C11 and Botswana IgG2 serum
Table 1: List of phage displayed peptides and their corresponding MmmSC proteins identified after selection with the indicated 
antibody subpopulations from animal C11 and the Botswana outbreak
Mmm SC protein match Identified by serum from: Accession numbera Locus Tag
Animal C11c Botswana outbreakc
IgG panning
Putative variable surface protein Yes (3) ND CAE77433 MSC_0818
Cell division protein (FtsZ) Yes (1) ND CAE77211 MSC_0588
ABC transporter, substrate-binding component (Abc) Yes (1) ND CAE77420b MSC_0804
Prolipoprotein (Lpp) Yes (1) ND CAE77256 MSC_0635
D-lactate dehydrogenase (Ldh) Yes (2) ND CAE76687 MSC_0034
DNA gyrase subunit A (GyrA) Yes (2) ND CAE76660 MSC_0007
DNA gyrase subunit B (GyrB) Yes (1) ND CAE76659 MSC_0006
PTS system, glucose-specific, IIBC component (PtsG) Yes (4) ND CAE77485b MSC_0873
IgG2 panning
Transposase ISMmy1C Yes (1) No CAE77424 MSC_0808
30S ribosomal protein S5 (RpsE) Yes (1) No CAE77346 MSC_0728
Putative glucose-specific IIABC component (PtsG) Yes (1) No CAE76806 MSC_0161
Prolipoprotein (Lpp) Yes (1) No CAE77256 MSC_0635
Prolipoprotein LppC (LppC) Yes (1) No CAE76772 MSC_0122
Alanine-tRNA ligase (AlaS) Yes (1) No CAE76823 MSC_0178
DNA gyrase subunit B (GyrB) Yes (1) Yes (1) CAE76659 MSC_0006
Methionine adenosyltransferase (MetK) Yes (1) No CAE77120 MSC_0492
Glyceraldehyde-3-phosphate dehydrogenase (GapN) Yes (1) No CAE77137b MSC_0509
Glycerol-3-phosphate oxidase (GlpO) Yes (1) Yes (1) CAE76900b MSC_0259
D-lactate dehydrogenase (Ldh) Yes (1) No CAE76687 MSC_0034
P115-like protein with SMC_C motif Yes (7) No CAE77104 MSC_0476
Ribose/Galactose ABC transporter, ATP-binding component 
(RbsA)
Yes (3) No CAE76663 MSC_0010
Prolipoprotein B (LppB) Yes (2) Yes (5) CAE77147b MSC_0519
Glucose inhibited division protein A (GidA) Yes (1) No CAE77646 MSC_1042
ABC transporter, substrate-binding component (Abc) Yes (4) Yes (1) CAE77420b MSC_0804
Fructose-bisphosphate aldolase class II (FbaA2) Yes (1) No CAE76786 MSC_0139
IgA panning
Glyceraldehyde-3-phosphate dehydrogenase (NADP) (GapN) Yes (1) No CAE77137b MSC_0509
Prolipoprotein B (LppB) No Yes (3) CAE77147b MSC_0519
ABC transporter, substrate-binding component (Abc) No Yes (2) CAE77420b MSC_0804
CTP synthase (CtrA) Yes (1) No CAE76781 MSC_0134
Prolipoprotein LppC (LppC) No Yes (1) CAE76772 MSC_0122
Thioredoxin reductase (NADPH) (TrxB) Yes (1) No CAE77547 MSC_0938
Asparagine-tRNA ligase (AsnS) Yes (1) No CAE76732 MSC_0080
a EMBL/GenBank accession numbers for the protein sequences.
b Proteins that were expressed in this study (see Figure 3).
c Figures in parenthesis indicate numbers of peptides selected
ND - not determinedBMC Microbiology 2009, 9:215 http://www.biomedcentral.com/1471-2180/9/215
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antibodies. The PTS system, glucose-specific IIBC compo-
nent (PtsG) was identified by four peptides (Figure 2).
Expression and antigenicity of MmmSC polypeptides
Given the difficulty of easily expressing recombinant myc-
oplasmal proteins due to codon usage, a short list of genes
to be expressed in E. coli was compiled. Based on predeter-
mined selection criteria discussed below and using algo-
rithms for antigenicity and surface location together with
knowledge of their established characteristics, this list
comprised the ABC transporter Abc, GapN, GlpO, LppB
and PtsG. Site-directed mutations allowed 62% of the
ABC transporter Abc (residues 184 to 477), 96% of GlpO
(residues 6 to 380) and 61% of LppB (residues 1 to 376)
to be expressed. Fifty percent of GapN (residues 88 to
322) and 38% of the PtsG (residues 421 to 676) polypep-
tides could be expressed without mutating (Figure 2).
Four of the resulting recombinant polypeptides were
found in the E. coli insoluble pellet fraction. Their Mrs
were within the range expected from their amino acid
sequences. The calculated Mrs were: ABC transporter Abc,
Mr ~33 kDa; GapN, Mr ~26 kDa; GlpO, Mr ~41 kDa; and
LppB, Mr 43 ~kDa (compare with Figure 3). PtsG was iso-
lated from the soluble fraction using nickel chelation, but
it manifested in PAGE as two bands with Mrs ~70 and ~45
kDa (Figure 3; calculated Mr ~28 kDa).
The pool of the seven sera obtained from the Botswana
outbreak was also used in immunoblotting. The pool
reacted with the expressed Abc and LppB polypeptides
(Figure 4). The PtsG polypeptide bands were probed sep-
arately with serum obtained from an experimental infec-
tion. This immunoblot, however, showed multiple bands
that apparently reacted with the pooled sera (not shown).
Discussion
When a pathogen infects an animal, its epitopes leave an
"imprint" in the form of a spectrum of disease-specific
antibody paratopes in the serum. Most animals are there-
fore likely to have antibodies directed against a large
number of foreign epitopes. The strategy pursued in this
study was to use this complex mixture of antibodies to
select binders from a limited repertoire of sequences
derived from the genome of MmmSC, thereby focussing
the phage display selection process on relevant epitopes.
These binders were matched to open reading frames
present in the genome. Unlike immunoblotting, this
approach also identified the genes that coded for the anti-
genic proteins.
Schematic representation showing alignment of the five  selected proteins with phage displayed peptides obtained  with CBPP immune sera Figure 2
Schematic representation showing alignment of the 
five selected proteins with phage displayed peptides 
obtained with CBPP immune sera. The entire open 
reading frames that code for the five proteins (Abc, GapN, 
GlpO, LppB and PtsG) selected for expression aligned with 
the phage displayed immunogenic polypeptides that were iso-
lated by panning the fragmented MmmSC genome phage dis-
play library against CBPP immune sera. Asterisks indicate 
peptides isolated more than once and the numbers in paren-
theses specify the number of repeated isolations for such 
peptides.
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Expression of the five selected proteins in E. coli Figure 3
Expression of the five selected proteins in E. coli. SDS-
PAGE (10%) showing segments of the protein antigens that 
were expressed in E. coli. Lanes: M, molecular mass stand-
ards; 1, 12 μg of total antigen of MmmSC strain 8740; 2-6, 
expressed segments of proteins Abc, GapN, GlpO, LppB and 
PtsG, respectively.
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The fragmented genome library covered approximately
97% of the mycoplasmal genome. While adequate for its
purpose, it cannot, however, be considered to have been
completely random since among the 1016 proteins
encoded in the genome of MmmSC type strain PG1, 797
(78.4%) contain at least one UGAtrp codon, which is read
as stop codon in E. coli. Moreover, the frequency of UGAtrp
codons in coding sequences of MmmSC genes is relatively
high: 1.00% in contrast to 0.05% of UGGtrp codons. This
means that epitopes containing such stops could be dis-
rupted. Moreover, in a phage display system, the secreted
phages would be unlikely to display large oligopeptides or
those that resisted being transported through the bacterial
membrane or periplasm. The functionality of the library
was therefore first tested by selecting peptides with a pol-
yclonal rabbit antiserum directed against a single recom-
binant MmmSC polypeptide, i.e., the C-terminal proline-
rich portion of ORF5. The ORF5 gene product [22] corre-
sponds to the 486 aa protein having EMBL/GenBank
accession number CAE77151 [5]. The ORF5 antiserum
selected a series of overlapping peptides thereby identify-
ing a B cell epitope and confirming that polyclonal serum
could specifically select antigenic peptides from the phage
displayed repertoire. A further important indication that
the peptides had been specifically selected was that prior
to panning, only 12.5% of the sequenced inserts con-
tained in the library were both in-frame and in the correct
orientation for translation as mycoplasmal peptides. In
contrast, after panning, all were in-frame and without
stops. This finding, together with the way in which immu-
noselection yielded multiple copies of some peptides
(particularly those that overlapped but were not identi-
cal), provided additional evidence that the strategy was
essentially sound.
While 26 different MmmSC genes matched sequences
selected by phage display, those chosen for expression in
E. coli were required to have fulfilled criteria which were
considered to have a bearing on their usefulness as possi-
ble vaccine antigens. Firstly, since the pathogen enters the
animal via the nasal passages, preference was given to
genes selected by IgA from Mali and Botswana. Secondly,
only genes that were identified by multiple overlapping
copies of each phage displayed peptide qualified. Thirdly,
peptides that fulfilled the first two criteria, but which were
selected with a negative bovine serum were excluded.
Finally, the protein's likely function or structural position
was taken into account with a focus on previously-identi-
fied membrane-associated proteins [23] which also ful-
filled antigenicity criteria as predicted by bioinformatics
analyses. Although not excluded as being potentially use-
ful, any overlapping sequences that coded for internally
located proteins e.g. the DNA gyrase subunit B (Table 1)
were not investigated in this study. Applying these criteria
allowed us to focus on the ABC transporter, substrate-
binding component protein (Abc), the glyceraldehyde-3-
phosphate dehydrogenase (GapN), the glycerol-3-phos-
phate oxidase (GlpO), the prolipoprotein B (LppB) and
the PTS system, glucose-specific IIBC component (PtsG)
for expression in E. coli. By applying these criteria we do
not exclude further studies on any of the other apparently
antigenic proteins as vaccine or diagnostic targets. Even
though the proliporotein LppC fulfilled our criteria, some
of the peptides which matched the amino acid sequence
included sequences of unknown origins which did not
align with the target ORF (not shown).
ABC transporter proteins act on a wide variety of sub-
strates that include sugars, peptides, proteins and toxins
[24]. For example, the ATP-binding cassette (ABC) trans-
porter GtsABC together with GlpO forms part of the glyc-
erol catabolism pathway associated with MmmSC
virulence [25,26]. GlpO itself has been identified as a sig-
nificant MmmSC virulence factor [27-29]. GapN, in con-
trast, may play a role in transcription [30] and apoptosis
[31]. Membrane lipoproteins that interact with host cells
can stimulate the release of pro-inflammatory cytokines
[32] and are major antigens [23,33,34]. The lipoprotein
(LppB) identified by the phage display is found in African
and Australian strains of MmmSC, but not in the less viru-
Chemiluminescent immunoblot Figure 4
Chemiluminescent immunoblot. Recognition of the 
ABC transporter Abc (lane 1) and lipoprotein LppB (lane 4) 
polypeptides that were expressed in E. coli by a pool of sera 
obtained from cattle that were naturally infected with CBPP 
during the 1995 Botswana outbreak. The GapN (lane 2) and 
GlpO (lane 3) polypeptides were not recognised in this test 
format.
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lent European strains [22]. The ptsG gene, which occurs in
duplicate in many MmmSC strains [35], encodes the per-
mease of the phosphoenolpyruvate:glucose phospho-
transferase system. It has also been implicated in
intraclonal antigenic variation [36], a possible factor in
the evasion of the host immune response. With the excep-
tion of GapN, these proteins are likely to be involved in
pathogenicity or to be accessible to B cell receptors. They
therefore have potential either in vaccine or diagnostics
development. Only two of the expressed polypeptides,
however, reacted in immunoblots, possibly because their
epitopes in the denatured state most faithfully resembled
the phage displayed peptides that were originally bound
in the selection process. Although phage display of neces-
sity identified B cell epitopes, it is not yet clear whether it
is this response, or a cell-mediated one based on CD4
[37], which is a primarily responsible for protection. The
proteins identified using phage display will therefore also
need to be tested for their ability to cause primed lym-
phocytes to proliferate and produce IFNγ.
Conclusion
Constructing a phage library that displays peptides
derived from the actual organism of interest made it pos-
sible to narrow the search for genes that code for antigenic
and hence potentially immunogenic proteins of the myc-
oplasma that causes CBPP. Because of their interaction
with antibodies in the serum of infected animals, these
proteins may be regarded as potential vaccine targets, in
particular those selected using IgG2 and IgA. A model
epitope discovery system has shown that many antigenic
peptides obtained from such phage libraries have poten-
tial as vaccine antigens [38]. It may therefore also be
worth examining the actual antigenic MmmSC peptides
that were selected from the epitope library as possible
components of a subunit vaccine. Knowing which pro-
teins are antigenic may help to identify targets for generat-
ing knockout mutants for use as genetically defined
vaccines [39]. Lastly, phage display was able to identify
polypeptides that were recognised in immunoblotting by
serum from animals that were affected by a natural disease
outbreak. As well as having potential as vaccine antigens,
such peptides may be useful diagnostic targets.
Methods
Strains, growth conditions and vectors
MmmSC strain 8740 from Cameroon, provided by Dr. L.
Dedieu, CIRAD-EMVT, Montpellier, France, was cultured
in PPLO broth medium (Difco, Detroit, MI, USA) con-
taining thallium acetate (1% w/v), ampicillin (0.5 mg/
ml), heat-inactivated horse serum (20%) [40] and supple-
mented with 0.1 volumes of 25% fresh yeast extract. Myc-
oplasmas were grown at 37°C in 5% CO2 until stationary
growth phase and harvested by centrifugation at 20000 g
for 20 min. For genetic manipulation and subcloning, E.
coli strains TG1 (Stratagene, La Jolla, CA, USA), DH5α,
Top10 (Invitrogen, Carlsbad, CA, USA) and BL21 Star™
(DE3) (Invitrogen) were used. The phage display vector
fdtet 8.53 was a gift from Dr. V. K. Chaudhary, University
of Delhi, New Delhi, India.
Antisera, antibodies, and immunoblot analysis
Anti-ORF5 immune serum was obtained by injecting rab-
bits with amino acid residues 328-478 of the 486 aa pro-
line-rich  MmmSC ORF5 [22]. Bovine sera and
bronchoalveolar lavage (BAL) from animals C11 (recov-
ered from a sub-acute to chronic experimental infection)
and T1 (uninfected control) were from Dr. M. Niang, Cen-
tral Veterinary Laboratory, Bamako, Mali [4,19]. The
seven bovine sera used in screening and immunoblotting
were a kind gift from the Botswana National Veterinary
Laboratory in Gabarone, Botswana [18]. Antibodies were
isolated using ImmunoPure® Protein G columns (Pierce,
Rockford, IL, USA). Antibody-containing fractions were
applied to Excellulose™ GF-5 Desalting columns (Pierce).
Before selection by panning, unwanted filamentous
phage antibodies were removed from the C11 serum by
cross-absorption [41]. BAL IgA from animal C11 and
serum IgA from Botswana cattle were used in pannings,
but a limited volume was available and the samples were
not cross-absorbed. Negative control pannings using BAL
IgA and total IgG from the control animal (T1) were also
performed.
Immunoblotting was performed according to standard
protocols. A volume of 10 μl of each of the seven sera
from Botswana were added to 5 ml of 1% milk powder
(MP) suspended in PBS, pH 7.4. Blots were incubated
overnight in the pool of diluted sera at room temperature.
For the detection of bound antibodies, sheep horseradish
peroxidise conjugated anti-bovine IgG (catalogue No.
PP200; The Binding Site, Birmingham, UK) was diluted
1:10000 and incubated with the blot for an hour at room
temperature. Bound antibodies were detected after incu-
bation of the blot with SuperSignal® West Pico chemilu-
minescent substrate (Pierce) using the Lumi-Imager from
Roche Molecular Biochemicals.
Display library construction
Phage library construction using the pIII phage display
vector fdtet 8.53 was as described by Gupta and co-work-
ers [42]. This entailed ligating blunt-ended fragments of
MmmSC genomic DNA in the presence of the restriction
enzyme SrfI and T4 DNA ligase. The extent to which the
genome was represented in the primary library with a the-
oretical probability of 0.99 was calculated using the
method of Clarke and Carbon [43]. To deplete the result-
ing phage repertoire of any peptides that may have been
susceptible to binding by irrelevant antibodies present in
healthy bovine serum, a 50 μl volume was incubated withBMC Microbiology 2009, 9:215 http://www.biomedcentral.com/1471-2180/9/215
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2 mg of naïve bovine IgG at 4°C overnight. Any phage/
IgG aggregates were removed by centrifugation for 5 min
at 15000 g and the supernatant transferred to a new tube.
The depleted library was stored at 4°C.
Affinity selection from the phage library
The peptide display library was subjected to three succes-
sive rounds of affinity selection essentially as described
[15]. For selection of fusion phages from the library with
IgG2a or IgA antibodies, the polystyrene Petri dish (Fal-
con 1007; Becton Dickinson, Lincoln Park, NJ, USA) used
for panning was first coated with antibodies specific for
the desired bovine immunoglobulin subclass at a concen-
tration of approximately 20 μg/ml before the blocking
step.
Identification of antigens
Sequences of phage displayed peptides were compared
with the EMBL/GenBank database using the BLAST pro-
grams [44]. Flexibility, hydrophilicity, polarity and sur-
face properties were scored using the programs Bcepred
http://www.imtech.res.in/raghava/bcepred/ and BepiPred
http://www.cbs.dtu.dk/services/BepiPred/[21,45].
Cloning, site-directed mutagenesis, expression and 
purification of proteins
For expression, the relevant sequences of the targeted
genes were amplified from genomic DNA and cloned in
the pET100/D-TOPO® E. coli expression vector (Invitro-
gen), or in the case of PtsG, in the pQE-TriSystem
His·Strep  2 vector (Qiagen). Site-directed mutagenesis
(QuikChange Site-Directed mutagenesis kit; Stratagene)
was used to change mycoplasmal UGAtrp codons to E. coli
UGGtrp codons. Transformed E. coli cells were inoculated
into Overnight Express Instant TB medium from Novagen
(Madison, WI, USA). Following overnight induction, bac-
terial cells were lysed using Novagen BugBuster® reagent,
after which the supernatant fluids and cell pellets were
analysed by SDS-PAGE and immunoblotting on a PVDF
membrane using standard protocols. Proteins for PAGE
analysis were purified by using ProBond nickel chelate
chromatography kits as described by the manufacturer
(Invitrogen).
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